Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients

Not yet recruiting

• Conditions: Hemolytic Anemia

• Registration Number: NCT06708728
• Lead Sponsor: Sohag University

Brief Summary

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.

And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-11
• Study First Submitted: 2024-11-22
• Study First Submitted QC: 2024-11-26
• Last Update Submitted: 2024-11-26
• Study First Posted: 2024-11-27
• Last Update Posted: 2024-11-27
• Study Start: 2024-12
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Adults aged 18 years and older.
• Patients diagnosed with acquired hemolytic anemia.
• Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
• Patients (or their legal representatives) must provide informed

Exclusion Criteria

• Patients with underlying neoplastic diseases.
• Patients with hereditary hemolytic anemia.
• Patients or their representatives who do not consent to participate in the study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
intensive care unit admission of the patients due to progression of the disease complications.	through study completion, an average of 6 months	Primary outcome will be ICU admission due to progression of the disease complications.

Secondary Outcome Measures

Name	Time	Method
mortality within duration of hospital admission	through study completion, an average of 6 months	Secondary outcome will be mortality within duration of hospital admission

Trial Locations

Locations (1)

Faculty of Medicine Sohag University; 🇪🇬 Sohag, Egypt